IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 214 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $540,820 | -34.6% | 56,160 | -27.8% | 0.27% | -37.0% |
| Q2 2023 | $827,260 | +4.5% | 77,750 | +3.4% | 0.43% | +1.6% |
| Q1 2023 | $791,303 | -12.7% | 75,219 | +2.8% | 0.43% | -24.9% |
| Q4 2022 | $906,427 | +20.7% | 73,158 | +0.9% | 0.57% | +6.6% |
| Q3 2022 | $751,000 | -10.2% | 72,513 | 0.0% | 0.53% | -8.9% |
| Q2 2022 | $836,000 | -7.8% | 72,513 | +0.5% | 0.58% | +19.7% |
| Q1 2022 | $907,000 | +7.2% | 72,124 | -0.6% | 0.49% | +17.6% |
| Q4 2021 | $846,000 | -10.7% | 72,586 | 0.0% | 0.42% | +68.0% |
| Q3 2021 | $947,000 | +1.4% | 72,586 | 0.0% | 0.25% | +28.0% |
| Q2 2021 | $934,000 | +18.8% | 72,586 | +3.2% | 0.19% | +17.7% |
| Q1 2021 | $786,000 | – | 70,343 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |